Mersana Therapeutics Inc. (MRSN)
NASDAQ: MRSN
· Real-Time Price · USD
7.14
-0.28 (-3.77%)
At close: Aug 15, 2025, 3:59 PM
7.44
4.20%
After-hours: Aug 15, 2025, 06:16 PM EDT
Mersana Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 34.77M | 34.01M | 40.5M | 34.84M | 29.94M | 38.3M | 36.85M | 40.84M | 38.72M | 32.35M | 26.58M | 11.9M | 6.34M | 2.07M | 44K | 44K | 44K | 829K |
Cost of Revenue | n/a | n/a | n/a | 447K | 874K | 1.2M | 1.52M | 1.35M | 51.56M | 92.47M | 92.36M | 129.44M | 114.08M | 104.8M | 132.01M | 117.5M | 98.77M | 82.23M |
Gross Profit | 31.71M | 34.01M | 40.5M | 34.39M | 29.06M | 37.1M | 35.34M | 39.49M | -12.85M | -60.12M | -65.78M | -117.54M | -107.74M | -102.73M | -131.97M | -117.46M | -98.73M | -81.4M |
Operating Income | -51.39M | -76.85M | -73.34M | -79.45M | -109.04M | -137.89M | -172.07M | -197.25M | -215.23M | -212.68M | -204.03M | -205.93M | -191.67M | -180.75M | -168.83M | -149.59M | -126.61M | -105.58M |
Interest Income | 5.63M | 6.9M | 8.44M | 9.77M | 11.1M | 12.15M | 12.07M | 11.01M | 8.41M | 5.49M | 2.88M | 1.05M | 353K | 71K | 65K | 46K | 50K | 130K |
Pretax Income | -73.62M | -73.59M | -68.77M | -74.2M | -104.77M | -134.81M | -171.67M | -197.05M | -215.21M | -213.12M | -204.21M | -208.27M | -193.93M | -182.63M | -170.06M | -149.92M | -126.94M | -105.81M |
Net Income | -74.04M | -74.01M | -69.19M | -74.62M | -104.77M | -134.81M | -172.65M | -199M | -217.15M | -215.06M | -205.9M | -209M | -194.66M | -183.35M | -170.06M | -149.92M | -126.94M | -105.81M |
Selling & General & Admin | 35.09M | 38.18M | 40.39M | 41.19M | 44.22M | 51.91M | 59.1M | 64.21M | 65.89M | 62.51M | 56.96M | 52.83M | 48.38M | 42.46M | 36.89M | 32.13M | 27.89M | 24.17M |
Research & Development | 71.65M | 72.67M | 73.02M | 72.23M | 87.96M | 119.68M | 148.27M | 172.48M | 192.59M | 184.85M | 173.38M | 165.04M | 149.68M | 140.4M | 132.01M | 117.5M | 98.77M | 82.23M |
Other Expenses | 3.94M | n/a | n/a | n/a | 8.21M | 8.21M | 8.21M | 8.21M | -172K | -172K | -172K | -1.12M | -952K | -1.04M | -1.04M | -86K | -159K | -73K |
Operating Expenses | 110.68M | 110.85M | 113.41M | 113.42M | 140.39M | 179.8M | 215.58M | 244.91M | 258.48M | 247.36M | 230.35M | 217.88M | 198.06M | 182.87M | 168.9M | 149.63M | 126.66M | 106.41M |
Interest Expense | 1.99M | 3.65M | 3.87M | 4.02M | 4.05M | 4.09M | 4.07M | 3.99M | 3.85M | 3.59M | 3.33M | 3.35M | 2.56M | 1.9M | 1.27M | 378K | 372K | 364K |
Selling & Marketing Expenses | n/a | n/a | -423K | -870K | -870K | -870K | -447K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 83.11M | 110.85M | 113.83M | 114.29M | 141.26M | 180.67M | 216.03M | 244.91M | 258.48M | 247.36M | 230.35M | 217.88M | 198.06M | 182.87M | 168.9M | 149.63M | 126.66M | 106.41M |
Income Tax Expense | 418K | 418K | 418K | 418K | -6.36M | -6.68M | -5.7M | -4.73M | 1.41M | 2.02M | 1.77M | 802K | 1.03M | 533K | -179K | -169K | -184K | 111K |
Shares Outstanding (Basic) | 4.98M | 4.98M | 4.94M | 4.91M | 4.9M | 4.86M | 4.82M | 4.82M | 4.62M | 4.3M | 4.04M | 3.91M | 3.83M | 3.2M | 2.88M | 2.87M | 2.78M | 2.76M |
Shares Outstanding (Diluted) | 4.98M | 4.98M | 4.94M | 4.91M | 4.9M | 4.86M | 4.82M | 4.82M | 4.62M | 4.3M | 4.04M | 3.91M | 3.83M | 3.2M | 2.88M | 2.87M | 2.78M | 2.76M |
EPS (Basic) | -10.05 | -15.01 | -14.13 | -15.32 | -21.62 | -28.4 | -37.49 | -44.56 | -51.23 | -53.12 | -54.84 | -60.75 | -61.28 | -62.34 | -60.13 | -53.64 | -46.02 | -39.47 |
EPS (Diluted) | -10.05 | -15.01 | -14.13 | -15.32 | -21.62 | -28.4 | -37.49 | -44.56 | -51.23 | -53.12 | -54.84 | -60.75 | -61.28 | -62.34 | -60.13 | -53.64 | -46.02 | -39.47 |
EBITDA | -45.54M | -68.42M | -63.27M | -68.51M | -99.02M | -129.1M | -166.08M | -191.71M | -210.22M | -208.49M | -199.96M | -204.07M | -190.51M | -179.89M | -167.94M | -148.64M | -125.62M | -104.46M |
EBIT | -46.66M | -69.94M | -64.9M | -70.18M | -100.72M | -130.72M | -167.6M | -193.06M | -211.35M | -209.53M | -200.88M | -204.93M | -191.37M | -180.73M | -168.79M | -149.54M | -126.57M | -105.45M |
Depreciation & Amortization | 1.12M | 1.52M | 1.63M | 1.68M | 1.7M | 1.62M | 1.52M | 1.35M | 1.14M | 1.04M | 927K | 856K | 855K | 834K | 855K | 904K | 948K | 988K |